Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Fulcher

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Blood|October 1, 1989
Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralizationD Scandella, M Mattingly, S de Graaf, et al.
Blood|May 1, 1987
FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblottingC A Fulcher, S de Graaf Mahoney, T S Zimmerman
Blood|October 1, 1989
An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII moleculeM Shima, J Ware, A Yoshioka, et al.
Thrombosis and Haemostasis|June 28, 1990
A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
Blood|February 1, 1984
Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor VC A Fulcher, J E Gardiner, J H Griffin, et al.
The Journal of Biological Chemistry|April 15, 1988
An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
The Journal of Clinical Investigation|July 1, 1985
Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopesC A Fulcher, J R Roberts, L Z Holland, et al.
Blood|May 15, 1990
Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserineP A Foster, C A Fulcher, R A Houghten, et al.
Blood|November 1, 1983
Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigenM J Weinstein, C A Fulcher, L E Chute, et al.
The Journal of Biological Chemistry|June 25, 1987
A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factorP A Foster, C A Fulcher, T Marti, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Blood|October 1, 1989
Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralizationD Scandella, M Mattingly, S de Graaf, et al.
Blood|May 1, 1987
FVIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblottingC A Fulcher, S de Graaf Mahoney, T S Zimmerman
Blood|October 1, 1989
An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII moleculeM Shima, J Ware, A Yoshioka, et al.
Thrombosis and Haemostasis|June 28, 1990
A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
Blood|February 1, 1984
Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor VC A Fulcher, J E Gardiner, J H Griffin, et al.
The Journal of Biological Chemistry|April 15, 1988
An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.
The Journal of Clinical Investigation|July 1, 1985
Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopesC A Fulcher, J R Roberts, L Z Holland, et al.
Blood|May 15, 1990
Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserineP A Foster, C A Fulcher, R A Houghten, et al.
Blood|November 1, 1983
Apparent molecular weight of purified human factor VIII procoagulant protein compared with purified and plasma factor VIII procoagulant protein antigenM J Weinstein, C A Fulcher, L E Chute, et al.
The Journal of Biological Chemistry|June 25, 1987
A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factorP A Foster, C A Fulcher, T Marti, et al.
Pageof 3